cellvie
PrivateLast Round
Seed
Feb 6, 2023
Total Funding Raised
$10.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
cellvie operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Seed round in February 2023.
cellvie is a biotechnology company that develops mitochondria-based therapeutic technology intended to restore cellular bioenergetics and improve organ function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cellvie Comparables
Compare cellvie with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LUCA Science | 83% | |
| MitoSense, Inc. | 78% | |
| PAEAN Biotechnology | 77% |
For institutional investors. Book with your work email.
cellvie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 6, 2023 | ||||
| Seed | Jan 25, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
cellvie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
| Taiho Ventures | Seed |
| Oscar & Paul Beiersdorf Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 697% MoM, from 144 to 1.1K.
- Jan 7, 2026
Monthly visitors increased 133% MoM.
For institutional investors. Book with your work email.
cellvie Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about cellvie's valuation, stock price, and market status.
Is cellvie a public or private company?
cellvie is a private company.
What is the current stock price of cellvie?
cellvie is a private company, so its shares have no public market price. Caplight tracks cellvie's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is cellvie worth (valuation)?
Valuation information for cellvie is not publicly available.
Can I buy cellvie stock?
cellvie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was cellvie's last funding round?
cellvie's most recent funding round was Seed on February 6, 2023.
Who are the main investors in cellvie?
Key investors in cellvie include Kizoo Technology Capital, Taiho Ventures.
Will cellvie IPO soon?
No public IPO plans have been announced for cellvie.
How can I track cellvie secondary market activity?
Caplight tracks bids, offers, and trades in cellvie's shares on secondary markets.